New approaches to the treatment of rheumatologic diseases have been discussed today at the Eurasian Congress in Minsk. The event featured over 2,000 experts from Armenia, Belarus, Georgia, Italy, Kazakhstan, Moldova, Russia and Ukraine. Also, leading Belarusian pharmaceutical companies presented their products. Following the Congress, a resolution that will help coordinate joint actions to combat rheumatologic diseases will be adopted.
